Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05078723 · ClinicalTrials.gov registry record · NA
CYP2C19 Variants and Limonene Metabolism
A NA study of CYP2C19 Genetic Variants, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05078723 is a NA study of CYP2C19 Genetic Variants that is actively recruiting participants, run by Stanford University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05078723, a NA study of CYP2C19 Genetic Variants, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will examine whether a non-invasive screening tool for CYP2C19 genetic variants can be developed by measuring limonene metabolism.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Limonene
Study Locations (1)
California
- Stanford School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-30 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05078723
The ClinicalTrials.gov registry entry for NCT05078723 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with CYP2C19 Genetic Variants appearing as the primary indexed condition, and to 1 intervention - of which Limonene is the first listed.
NCT05078723 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05078723 about?
NCT05078723 is a clinical study titled "CYP2C19 Variants and Limonene Metabolism". The investigators will examine whether a non-invasive screening tool for CYP2C19 genetic variants can be developed by measuring limonene metabolism.
What is the current status of trial NCT05078723?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-10-30. Estimated completion is 2026-12.
What conditions does trial NCT05078723 study?
This clinical trial studies the following conditions: CYP2C19 Genetic Variants.
What interventions are being tested in trial NCT05078723?
The interventions under investigation include: Limonene (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05078723?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05078723 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.